News
At the core of Quetzal’s mission is a belief that cutting-edge science, guided by proven leadership, can redefine what’s possible in treatment for conditions like Acute Promyelocytic Leukemia (“APL”) ...
About eMI eMI Aesthetics is an innovative AI-powered platform that empowers users to explore aesthetic treatments visually, privately, and confidently. With no downloads, instant simulation, and ...
Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies; Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal ...
Constant Therapy today announced a first-in-state collaboration with New York-based Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients with stroke, brain ...
Quarterly consolidated revenue Our second-quarter revenue reached €363.1 million, marking a +6.4% increase at constant exchange rates and scope compared to the same period in 2024. This strong ...
NANTES, France - July 16, 2025, 6:00pm CET – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following assets were recorded on the liquidity account as of ...
Phased Rollout The platform will initially feature Full Alliance Group–owned or licensed products, including popular wellness lines Feromos and Jusspray HOCl. Future phases will open the network to ...
This U.S.-based manufacturing agreement builds upon Oragenics’ broader strategy to develop scalable, accessible, and fast-acting treatments for neurological trauma, beginning with concussion, a ...
Nasdaq's determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable initial listing standards for The Nasdaq ...
Two remaining SPC-15 studies are currently in progress or being planned: an IND-enabling GLP (Good Laboratory Practice)-compliant toxicology and toxicokinetic animal study, and a device study of ...
NeuroRush™ delivers a unique blend of adaptogens and nootropic herbs designed to enhance cognitive performance, stress response and long-term brain health, without dependency or burnout.
The CardiAMP HF cell therapy trials are important for patients with ischemic heart failure in need of new therapies,” said Gerald Koenig, MD, Director of the Cardiac Catheterization Laboratory, Henry ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results